Have your own idea? Try our Stock Screener
UPDATED Dec 21, 2024
Discover small cap German Pharmaceuticals & Biotech companies that are on the DAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
PA8K | €0.0094 | -9.6% | 840.0% | €67.1k | n/a | PE-0.003x | n/a | n/a | ||
27N0 | €0.30 | 0% | -84.1% | €138.6k | n/a | n/a | n/a | n/a | ||
CNW | €0.007 | -6.7% | -41.7% | €187.1k | n/a | n/a | n/a | n/a | ||
3YX | €0.001 | 0% | -50.0% | €314.1k | n/a | n/a | n/a | n/a | ||
SBH | €0.002 | 0% | -77.8% | €419.8k | n/a | PS3.8x | n/a | n/a | ||
T5O | €1.31 | 1.2% | -81.8% | €673.0k | n/a | PS134.8x | n/a | n/a | ||
BPXA | €0.064 | 0% | n/a | €772.4k | n/a | PE-0.04x | n/a | n/a | ||
ECX | €1.11 | -25.0% | -40.8% | €971.4k | n/a | PE0.3x | n/a | n/a | ||
991 | €1.00 | 0% | -16.7% | €2.3m | n/a | PS1.3x | n/a | n/a | ||
8X40 | €0.34 | 576.0% | n/a | €2.7m | n/a | n/a | n/a | n/a | ||
CNW | €0.24 | 0% | -84.5% | €6.5m | n/a | PB1x | n/a | n/a | ||
0K30 | €2.18 | 0% | -65.3% | €9.7m | n/a | PS8.7x | n/a | n/a | ||
20B | €0.11 | -11.8% | -20.0% | €10.2m | n/a | PS96.6x | n/a | n/a | ||
PJ2 | €3.80 | 0% | -0.7% | €11.8m | n/a | PS43.7x | S-149.8% | n/a | ||
B8FK | €2.23 | -9.2% | -73.7% | €13.5m | n/a | PB0.8x | n/a | n/a | ||
MDG1 | €1.03 | -10.0% | -63.9% | €15.2m | €2.00 | PS2x | E11.0% | n/a | ||
SBX | €5.36 | 0% | 79.3% | €26.8m | €12.45 | PS6.9x | E106.9% | n/a | ||
T9G | €0.63 | 14.5% | 37.0% | €32.5m | €4.91 | n/a | n/a | n/a | ||
VSC | €4.01 | -3.6% | -52.0% | €43.7m | n/a | PS121.9x | n/a | n/a | ||
HIGH | €5.15 | -9.6% | -27.7% | €64.2m | €11.75 | PE290.4x | E114.7% | n/a | ||
2INV | €11.70 | 0% | 72.1% | €67.3m | n/a | PE13.4x | n/a | n/a | ||
0RX | €0.17 | 0% | -50.9% | €65.0m | n/a | PS13.3x | E-22.3% | n/a | ||
7V0 | €27.60 | 0% | -20.2% | €82.8m | n/a | n/a | n/a | 8.2% | ||
APPH | €10.10 | 0.5% | 117.7% | €84.1m | €13.25 | PS2.1x | E78.1% | n/a |